Liliane Halab

Title: The Innovative Contributions of Inventor Liliane Halab

Introduction

Liliane Halab, an accomplished inventor based in Outremont, Canada, has made significant strides in the field of pharmaceutical innovations. With a total of five patents to her name, she has dedicated her work to developing compounds that address critical health challenges, particularly concerning viral infections.

Latest Patents

Among her latest patents, Halab has developed compounds represented by specific formulas that are suitable for treating or preventing Flaviviridae viral infections in hosts. This innovation includes pharmaceutically acceptable salts and related compounds. Furthermore, she has explored C-21-keto lupane derivatives, which relate to 21-keto triterpene compounds. These compounds exhibit notable anti-HIV activity, leading to methods for prevention or treatment of HIV infections through the administration of these therapeutic compounds.

Career Highlights

Throughout her career, Liliane Halab has been associated with prominent companies in the pharmaceutical field, including Vertex Pharmaceuticals (Canada) Incorporated and Vertex Pharmaceuticals, Inc. Her work has not only expanded the boundaries of pharmaceutical compounds but has also provided new avenues for treatment options for serious viral infections.

Collaborations

In her journey as an inventor, Halab has collaborated with esteemed colleagues such as Laval Chan Chun Kong and Oswy Z Pereira. These partnerships have enhanced her research and development endeavors, allowing for a richer exchange of ideas and innovations in the field of pharmaceuticals.

Conclusion

Liliane Halab stands out as a visionary inventor whose work has substantial implications for public health, particularly in the fight against viral infections. Through her extensive patent portfolio and collaborative spirit, she continues to pave the way for future innovations in medicine.